跳至主要内容
临床试验/IRCT20140312016968N2
IRCT20140312016968N2已完成未知

Pilot study of the Grapefruit seed extract adjuvant therapy on COVID-19

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Ages between 18-60 years
  • Inpatients of the wards
  • Daily Lopinavir / Ritonavir
  • PCR confirmed COVID-19
  • Without background disease

排除标准

  • Age above 60 and below 18
  • Cardiovascular disease
  • Autoimmune disease
  • Renal disease
  • Respiratory distress on admission time
  • Allergy history
  • Consumption of cardiovascular drugs, anti diabetes, anti coagulants, anti HIV, anti cholesterol, immunsuppressive, and cancer chemotherapy agents
  • Reluctance to participate in the study

研究者

相似试验

Study of the effects of grapefruit extract on... | 临床试验